Attached files
| file | filename |
|---|---|
| EX-31.1 - HNO International, Inc. | v235243_ex31-1.htm |
| EX-10.7 - HNO International, Inc. | v235243_ex10-7.htm |
| EX-31.2 - HNO International, Inc. | v235243_ex31-2.htm |
| EX-32.1 - HNO International, Inc. | v235243_ex32-1.htm |
| 10-Q - HNO International, Inc. | v235243_10q.htm |
Certification
In connection with the Quarterly Report on Form 10-Q of Clenergen Corporation (the “Company”) for the quarter ended July 31, 2011 (the “Form 10-Q”), I, Mike Starkie, the Acting Chief Financial Officer (Principal Financial Officer) of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:
|
(a)
|
The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(b)
|
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: September 19, 2011
|
/s/ Mike Starkie
|
|
Mike Starkie
|